Pancreatic Cancer Research

ResearcherPennsylvania State UniversityActive in the last 2 years

Madeline B. Torres

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112651535. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Novel Therapies Calls for Predictive Biomarkers: E2F7 in the Era of Perioperative S-1 for Pancreatic Cancer. First author DOI 10.1245/s10434-026-19631-z↗
  2. Undertreatment of Pancreatic Cancer: The Intersection of Bias, Biology, and Geography. Co-author DOI 10.1016/j.soc.2021.07.006↗
  3. Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival. Co-author DOI 10.1002/jso.26481↗
  4. Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology. Co-author DOI 10.1245/s10434-020-09546-8↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Oskar Franklin · 1 shared paper, 2026 · strength 0.63
  2. Niraj Jaysukh Gusani · 3 shared papers, 2021–2022 · strength 0.56
  3. Matthew E. B. Dixon · 3 shared papers, 2021–2022 · strength 0.56
  4. Chan Shen · 2 shared papers, 2021 · strength 0.30
  5. June S. Peng · 2 shared papers, 2021 · strength 0.30
  6. Elizabeth Josephine Olecki · 2 shared papers, 2021 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.